secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001493152-25-002448
Event type: regulatory
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics gets Nasdaq notice for missing annual meeting; sets Feb 21, 2025 meeting
--------------------------------------------------------------------------------

- Received Nasdaq notice on Jan 15, 2025 for failing to hold annual meeting within 12 months of FY 2023 end (Listing Rule 5620(a)).
- Company has scheduled annual meeting to occur no later than February 21, 2025 to regain compliance.
- No immediate effect on listing of PTIX or PTIXW on Nasdaq Capital Market.
- Will submit matter to Nasdaq Hearings Panel as part of ongoing listing discussions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225002448/0001493152-25-002448-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225002448/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002448

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer